Are there etiology-specific risk factors for adverse outcomes in patients on Impella 5.5 support?Central MessagePerspective por Jean-Luc A. Maigrot, BS, Lucy Thuita, MS, Michael Z.Y. Tong, MD, MBA, Edward G. Soltesz, MD, MPH, Nicholas G. Smedira, MD, MBA, Shinya Unai, MD, Randall C. Starling, MD, MPH, Andrew Higgins, MD, David Moros, MD, Eugene H. Blackstone, MD, Aaron J. Weiss, MD, PhD

Ligazón do recurso